drugset / Trial / NCT05920980
Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
Patients who meet the enrollment criteria will be randomized 1:1 to the lidocaine group or placebo group.
Timeline
- Start
- 2023-06-05
- Primary completion
- 2025-01-13
- Completion
- 2025-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |
| Subject | Lidocaine | Other / unclassified | 50 mg/kg | Intravenous |